Immunotherapy Esophagus Cancer (1)

Not yet recruiting (1)

phase 2 (1)

Fuzhou General Hospital (1)

albumin paclitaxel (1)

nedaplatin (1)

radiotherapy (1)

tislelizumab (1)

drug (1)

radiation (1)

Other (1)

Interventional (1)

immunotherapy esophagus cancer

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Aug 24, 2022